Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study Evaluating the Efficacy and Toxicity of Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer

NCT01494012 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01494012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01494012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study Evaluating the Efficacy and Toxicity of Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer
Lead sponsor
Stanford University
Phase
Phase 1
Overall status
Terminated
Start date
April 30, 2012
Completion date
September 30, 2012
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant tumor of peritoneum, recurrent ovarian epithelial cancer, recurrent ovarian germ cell tumor, stage iv ovarian epithelial cancer, stage iv ovarian germ cell tumor